BioHealth News Archive
Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members
FREDERICK, Md., June 16, 2021 /PRNewswire/ -- Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with…
Read MoreNational Academy of Inventors
This is the annual report published by the National Academy of Inventors (NAI) and the Intellectual Property Owners Association (IPO) on top university patent…
Read MoreNovavax Plans FDA Filing for COVID-19 Vaccine after Positive Efficacy Data
Novavax said today it will file for FDA approvals in the third quarter for its COVID-19 vaccine NVX-CoV2373, after it showed 90.4% overall efficacy,…
Read MoreLaboratory Technician – RNA Therapeutics Development in Gaithersburg, Maryland | BioBuzz Job Board
Starting immediately, miRecule, Inc. is looking for a Laboratory Technician to join its rapidly growing team in Gaithersburg, MD on the development of next…
Read MoreNew opportunities for students in science education; collaborative effort in Montgomery Co. | WDVM25 & DCW50 | Washington, DC
ROCKVILLE, Md. (WDVM) — More opportunities to come for college students in Maryland who are interested in STEM-related fields. Montgomery County is playing a…
Read MoreQ&A: Cushman & Wakefield’s Dan Hackett on Life Sciences Trends – Commercial Observer
The life sciences sector is hot, and that’s led to a rising interest among building owners in converting assets to lab, research and biotech…
Read MoreNovavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial | Novavax Inc. – IR Site
93% efficacy against predominantly circulating Variants of Concern and Variants of Interest 91% efficacy in high-risk populations 100% efficacy against variants "not considered Variants…
Read MoreWill the Biotech Industry Have the Right Talent for the Workforce of the Future? · BioBuzz
A few weeks ago, we wrote about how the BioHealth Capital Region’s (BHCR) biotech sector is booming. Advanced biomanufacturing, cell and gene therapy, vaccine…
Read MoreNovavax nearly ready to report latest Covid-19 vaccine trial data – Washington Business Journal
The Gaithersburg biotech expects more data on its latest vaccine trial within days. Image: Novavax's future headquarters is located at 700 Quince Orchard Road…
Read MoreMontgomery County, University System of Maryland, Montgomery College sign deal to work on life sciences innovation – Washington Business Journal
Maryland universities, Montgomery County government and the private sector are teaming up to capitalize on local momentum in life sciences created over the past…
Read MoreNovavax Offers U.S. a Fourth Strong Covid-19 Vaccine – The New York Times
Novavax, a small American company buoyed by lavish support from the U.S. government, announced on Monday the results of a clinical trial of its…
Read MoreBiden wants $6.5 billion for new health agency to speed treatments | Science | AAAS
The Biden administration today began to flesh out a proposal for a new agency—modeled on the military’s Defense Advanced Research Projects Agency (DARPA)—that would…
Read MoreBHI EIR Feedback Day July 21st. Register Now!
Are you a biohealth start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your…
Read MoreAdditional EiRs for SEED
BioHealth Innovation, Inc. (BHI), is a Montgomery County innovation intermediary that translates market-relevant research into commercial success by bringing together management, funding, and markets.…
Read MoreTargeting Metabesity 2021 – ACCELERATING ADVANCEMENTS IN GEROSCIENCE INTOMATERIAL AND EQUITABLE GAINS IN PUBLIC HEALTH
I am delighted to announce that FREE Registration is open for the annual Conference, Targeting Metabesity2021, organized by our colleagues Kinexum and the Kitalys…
Read More